Reuters logo
BRIEF-Cellectar Biosciences Q1 loss per share $0.24
May 11, 2017 / 8:16 PM / in 5 months

BRIEF-Cellectar Biosciences Q1 loss per share $0.24

May 11 (Reuters) - Cellectar Biosciences Inc:

* Cellectar Biosciences reports first quarter 2017 financial and corporate performance

* Q1 loss per share $0.24

* Additional capital will be required for operations beyond Q2 of 2018. Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below